Berenberg Starts Halozyme Therapeutics (HALO) at Buy

December 17, 2020 6:12 AM EST
Get Alerts HALO Hot Sheet
Price: $40.30 -0.62%

Rating Summary:
    15 Buy, 3 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 22 | Down: 13 | New: 29
Trade Now! 
Join SI Premium – FREE

Berenberg analyst Anita Dushyanth initiates coverage on Halozyme Therapeutics (NASDAQ: HALO) with a Buy rating and a price target of $50.00.


For an analyst ratings summary and ratings history on Halozyme Therapeutics click here. For more ratings news on Halozyme Therapeutics click here.


Shares of Halozyme Therapeutics closed at $41.11 yesterday.


You May Also Be Interested In





Related Categories

New Coverage